208 related articles for article (PubMed ID: 32182119)
1. Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223.
Abou DS; Rittenbach A; Tomlinson RE; Finley PA; Tsui B; Simons BW; Jha AK; Ulmert D; Riddle RC; Thorek DLJ
Cancer Biother Radiopharm; 2020 Sep; 35(7):520-529. PubMed ID: 32182119
[No Abstract] [Full Text] [Related]
2. Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis.
Abou DS; Ulmert D; Doucet M; Hobbs RF; Riddle RC; Thorek DL
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26683407
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
[TBL] [Abstract][Full Text] [Related]
4. Radium-223 in the treatment of osteoblastic metastases: a critical clinical review.
Humm JL; Sartor O; Parker C; Bruland OS; Macklis R
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):898-906. PubMed ID: 25832684
[TBL] [Abstract][Full Text] [Related]
5. The potential of
Murray I; Chittenden SJ; Denis-Bacelar AM; Hindorf C; Parker CC; Chua S; Flux GD
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1832-1844. PubMed ID: 28612079
[TBL] [Abstract][Full Text] [Related]
6. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates.
Jiang W; Ulmert D; Simons BW; Abou DS; Thorek DLJ
Nucl Med Biol; 2018; 62-63():1-8. PubMed ID: 29800797
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Thorium-227/Radium-223 Gamma-Camera Imaging During Radionuclide Therapy.
Larsson E; Brolin G; Cleton A; Ohlsson T; Lindén O; Hindorf C
Cancer Biother Radiopharm; 2020 Sep; 35(7):540-548. PubMed ID: 32486837
[TBL] [Abstract][Full Text] [Related]
8. Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from castration resistant prostate cancer.
Pratt BE; Hindorf C; Chittenden SJ; Parker CC; Flux GD
Nucl Med Commun; 2018 Feb; 39(2):125-130. PubMed ID: 29189490
[TBL] [Abstract][Full Text] [Related]
9. Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.
Benabdallah N; Scheve W; Dunn N; Silvestros D; Schelker P; Abou D; Jammalamadaka U; Laforest R; Li Z; Liu J; Ballard DH; Maughan NM; Gay H; Baumann BC; Hobbs RF; Rogers B; Iravani A; Jha AK; Dehdashti F; Thorek DLJ
Theranostics; 2021; 11(20):9721-9737. PubMed ID: 34815780
[No Abstract] [Full Text] [Related]
10. Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.
Carrasquillo JA; O'Donoghue JA; Pandit-Taskar N; Humm JL; Rathkopf DE; Slovin SF; Williamson MJ; Lacuna K; Aksnes AK; Larson SM; Scher HI; Morris MJ
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1384-93. PubMed ID: 23653243
[TBL] [Abstract][Full Text] [Related]
11. Detection and quantification of
Mínguez P; Gómez de Iturriaga A; Fernández IL; Rodeño E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):20-27. PubMed ID: 28645684
[TBL] [Abstract][Full Text] [Related]
12. ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for
Li Z; Benabdallah N; Luo J; Wahl RL; Thorek DLJ; Jha AK
J Nucl Med; 2024 May; 65(5):810-817. PubMed ID: 38575187
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases.
Chittenden SJ; Hindorf C; Parker CC; Lewington VJ; Pratt BE; Johnson B; Flux GD
J Nucl Med; 2015 Sep; 56(9):1304-9. PubMed ID: 26182965
[TBL] [Abstract][Full Text] [Related]
14. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why.
Gallicchio R; Mastrangelo PA; Nardelli A; Mainenti PP; Colasurdo AP; Landriscina M; Guglielmi G; Storto G
Tumori; 2019 Oct; 105(5):367-377. PubMed ID: 31096849
[TBL] [Abstract][Full Text] [Related]
15. [
Yang Y; Alencar LMR; Pijeira MSO; Batista BDS; França ARS; Rates ERD; Lima RC; Gemini-Piperni S; Santos-Oliveira R
Drug Deliv; 2022 Dec; 29(1):186-191. PubMed ID: 35191342
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Total Lesion Activity on
Filippi L; Basile P; Schillaci O; Bagni O
Cancer Biother Radiopharm; 2020 Aug; 35(6):398-403. PubMed ID: 32109140
[TBL] [Abstract][Full Text] [Related]
17. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases.
Yoshida K; Kaneta T; Takano S; Sugiura M; Kawano T; Hino A; Yamamoto T; Shizukuishi K; Kaneko M; Zurth C; Inoue T
Ann Nucl Med; 2016 Aug; 30(7):453-60. PubMed ID: 27272279
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.
Hindorf C; Chittenden S; Aksnes AK; Parker C; Flux GD
Nucl Med Commun; 2012 Jul; 33(7):726-32. PubMed ID: 22513884
[TBL] [Abstract][Full Text] [Related]
20. Compartmental Model for
Taprogge J; Murray I; Gear J; Chittenden SJ; Parker CC; Flux GD
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):884-892. PubMed ID: 31349058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]